Category: Allies & Partnerships
Five Melanoma Research Highlights to Look Forward to in 2021
By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment
At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.
Creating Art to Create Change: The Power to Heal & Mobilize Community
By Renee Orcione, MRA Development Associate | 11 January 2021 In Allies & Partnerships, Melanoma Stories
Following the initial shock of her diagnosis and the strain of facing treatments on her own, Barbara was faced with yet another hurdle. Her arm surgery had left it nearly immobile. Not only was this a problem for her daily functioning, it made it extremely difficult for Barbara to pursue her lifelong passion of art.
Fueling a Revolution: Driving Research Forward
21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment
MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.
Painting a Portrait of the Melanoma Clinical Trial Participant
By Cody R. Barnett, MRA Director of Communications | 26 June 2020 In Allies & Partnerships
MRA Chief Science Officer Marc Hurlbert, MRA Director of Communications Cody Barnett, and Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards discuss what matters most to melanoma patients when it comes to participating in clinical trials.
Maintaining Momentum in Melanoma Research
8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment
The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.
Facing Melanoma Together
By Cody R. Barnett, MRA Director of Communications | 20 May 2020 In Allies & Partnerships, Melanoma Stories
Measuring the progress of melanoma research through numbers isn’t hard. What’s harder to quantify – or to even put into words – is the individual impact that this research makes in the lives of patients and their loved ones. It's this human impact that Facing Melanoma Together, a series of black and white photographs, helps bring to the forefront.
Lighting up Melanoma (One Cell at a Time)
18 May 2020 In Allies & Partnerships, Prevention, Science, Treatment
Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.
Putting Healthy Skin First - L’Oréal Active Cosmetics Division & MRA Strengthen Longstanding L’Oréal and MRA Partnership
By Cody R. Barnett, MRA Director of Communications | 1 May 2020 In Allies & Partnerships, News, Science
Some partnerships just make sense. For example, L’Oréal-owned SkinCeuticals, CeraVe and La Roche-Posay apart of the L’Oreal Active Cosmetics Division and MRA both share a mission and ethos for promoting healthy skin. It is no surprise that the two are longtime partners in the fight against melanoma. In fact, these brands and MRA have just announced an expanded partnership just in time for Melanoma Awareness Month.
Keeping You Connected to the Melanoma Community
By Cody R. Barnett, MRA Director of Communications | 18 February 2020 In Allies & Partnerships
With the launch of the brand-new Inspire App, the Melanoma > Exchange community is getting even better. Available for iPhone and iPad – the app was designed from the ground up to make connecting and sharing even easier and as mobile as you are.
MRA is Raising the Treatment Bar
31 October 2019 In Allies & Partnerships, Melanoma Stories, Science, Treatment
We have made unprecedented progress that is transforming what it means to be diagnosed with melanoma. Today, we have more treatment options than ever before—in fact 12 new options have earned FDA approval since MRA's founding. But, it's still not enough.